Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a patient suffered a serious side effect or an unrelated illness.
J&J launches final study of COVID-19 vaccine
Reuters - Politics
The drug giant said it would begin a stage three trial of a single-shot vaccine, which could prove easier to administer than rivals..
